Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 5/20 | 1.00 |
| ▸ | SNCA | P37840 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | APEX1 | P27695 | 4/20 | 1.00 |
| ▸ | RECQL | P46063 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | RAD52 | P43351 | 2/20 | 1.00 |
| ▸ | CNR1 | P21554 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.74 |
| ▸ | GAA | P10253 | 3/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.74 |
| ▸ | PKM | P14618 | 2/20 | 0.74 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epigallocatechin SCHEMBL29870730 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL12840936 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL1972940 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| (-)-Gallocatechin SCHEMBL30159803 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL1972938 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL12285364 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL19553 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL20203645 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| (-)-Gallocatechin SCHEMBL1742127 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT | |
| Epigallocatechin SCHEMBL29929503 | 1.00 | BACE1 (1.00) | BACE1KDM4EPTGS1SNCAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 419 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107510-A1 | HOT-MELT ADHESIVE COMPOSITION AND METHOD OF APPLICATION | BIOBOND ADHESIVES, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4743071-A2 | DIPHENYLETHYLENE COMPOUNDS AND COMPOSITIONS THEREOF | INNOVENE INC. (US) | 2026-05-20 | — | — | EP | claimed |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | AQUILA BLACK LTD (AU) | 2026-05-14 | — | — | US | claimed |
| US-20260103663-A1 | ANTIMICROBIAL MATERIALS AND NANOPARTICLES AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2026-04-16 | — | — | US | claimed |
| US-20250367206-A1 | 1-METHYLXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF | Ingenious Ingredients, LP (US) | 2025-12-04 | — | — | US | claimed |
| WO-2025095473-A1 | NEGATIVE ELECTRODE ACTIVE MATERIAL, NEGATIVE ELECTRODE SLURRY, NEGATIVE ELECTRODE, AND SECONDARY BATTERY | 주식회사 엘지에너지솔루션 | 2025-05-08 | — | — | WO | claimed |
| EP-4547242-A1 | COMPOSITION FOR THE TREATMENT OF THE HUMAN PAPILLOMAVIRUS INFECTION (HPV) | LO.LI. Pharma S.r.l. (IT) | 2025-05-07 | — | — | EP | claimed |
| US-20250114324-A1 | ANTIMICROBIAL MATERIALS AND NANOPARTICLES AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2025-04-10 | — | — | US | claimed |
| US-20250064996-A1 | STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF | RAYZEBIO, INC. | 2025-02-27 | — | — | US | claimed |
| CN-119451673-A | Compositions for the treatment of Human Papillomavirus (HPV) infections | 洛利制药有限责任公司 | 2025-02-14 | — | — | CN | claimed |
| WO-2023009655-A1 | BIOACTIVE COMPOSITIONS AND METHODS OF USE THEREOF | Ingenious Ingredients, LP (US) | 2023-02-02 | — | — | WO | claimed |
| EP-4093296-A1 | PARAXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF | Ingenious Ingredients, LP (US) | 2022-11-30 | — | — | EP | claimed |
| US-20220331328-A1 | 1-METHYLXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF | Ingenious Ingredients, LP | 2022-10-20 | — | — | US | claimed |
| CN-115068465-A | Application of gallocatechin-7-gallate in anti-coronavirus drugs | 中国医学科学院药物研究所 | 2022-09-20 | — | — | CN | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-20220160734-A1 | TREATMENT OF FIBROIDS WITH VITAMIN D AND AN AGENT SUCH AS EPIGALLOCATECHIN GALLATE (EGCG) | LO.LI. PHARMA S.R.L. (IT) | 2022-05-26 | — | — | US | claimed |
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| EP-3397072-B1 | MIXTURES WITH STABILISING PROPERTIES | SYMRISE AG (DE) | 2019-07-24 | — | — | EP | claimed |
| EP-1448186-A1 | MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES | MediGene Aktiengesellschaft (DE) | 2004-08-25 | — | — | EP | claimed |
| WO-2003043628-A1 | MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES | MEDIGENE AKTIENGESELLSCHAFT (DE) | 2003-05-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103663-A1 | ANTIMICROBIAL MATERIALS AND NANOPARTICLES AND METHODS OF USE THEREOF | DSTN, RHOA, FLOT1 | BACE1 1024/4885KDM4E 2051/4885PTGS1 2604/4885 |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | TTPA, PNLIP, SRMS | BACE1 3685/4885KDM4E 4113/4885PTGS1 1473/4885 |
| US-20250064996-A1 | STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF | TFRC, SLC39A14, EGFR | BACE1 1741/4885KDM4E 3658/4885PTGS1 4873/4885 |
| US-20250114324-A1 | ANTIMICROBIAL MATERIALS AND NANOPARTICLES AND METHODS OF USE THEREOF | LPO, GPX4, NPC1L1 | BACE1 322/4885KDM4E 1321/4885PTGS1 2623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.